In 2023, Italy's share of scientific publications among the top 10% cited in drug discovery was 15.3%. The forecast indicates a steady increase from this base, rising annually to reach 16.31% in 2028. Year-on-year growth from 2024 to 2028 averages around 0.5% annually, showing a consistent upward trend. The compound annual growth rate (CAGR) over these five years reflects a positive trajectory for Italy's influence in high-impact drug discovery research.

Watch out for:

The impact of technological advancements on research output quality and visibility.
Increased international collaboration accelerating publication performance.
Governmental and private sector investments in pharmaceutical research driving future growth.